- Home
- MRK
as 04-18-2025 1:39pm EST
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Upcoming Earnings Alert:
Get ready for potential market movements as Merck & Company Inc. (new) MRK prepares to release earnings report on 24 Apr 2025.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | KENILWORTH |
| Market Cap: | 218.2B | IPO Year: | N/A |
| Target Price: | $119.86 | AVG Volume (30 days): | 19.8M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 6.74 | EPS Growth: | 4714.29 |
| 52 Week Low/High: | $75.93 - $134.63 | Next Earning Date: | 04-24-2025 |
| Revenue: | $64,168,000,000 | Revenue Growth: | 6.74% |
| Revenue Growth (this year): | 2.41% | Revenue Growth (next year): | 6.31% |
Stock Insider Trading Activity of Merck & Company Inc. (new) (MRK)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Downing Cristal N | MRK | Chief Comm. & Public Afrs Ofcr | Feb 6 '25 | Sell | $88.76 | 2,361 | $209,550.79 | 7,085 | |
| BAKER DOUGLAS M JR | MRK | Director | Feb 5 '25 | Buy | $88.50 | 15,000 | $1,327,500.00 | 16,000 |
Latest Merck & Company Inc. (new) News
MRK Breaking Stock News: Dive into MRK Ticker-Specific Updates for Smart Investing
Insider Monkey
2 days ago
Is Merck & Co., Inc. (MRK) The Dirt Cheap Stock To Invest In Now?
MT Newswires
2 days ago
BMO Capital Adjusts Merck Price Target to $89 From $96
Zacks
2 days ago
Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Insider Monkey
2 days ago
Merck & Co., Inc. (MRK): Among the Innovative Healthcare Stocks to Watch in 2025
Zacks
2 days ago
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
StockStory
2 days ago
Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
Morningstar Research
2 days ago
Analyst Report: Merck & Co., Inc.
Simply Wall St.
3 days ago
Merck (NYSE:MRK) Secures Global Rights To Cyprumed's Oral Peptide Delivery Technology
Compare MRK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MRK Merck & Company Inc. (new) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.